APRE vs AMZN · $10.4M cap vs P/E 31, rev $716.92B
Aprea Therapeutics Inc (APRE) versus Amazon.com Inc (AMZN) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
APRE does not have a complete income-statement cache yet.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
APRE currently screens at market cap $10.4M. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Not investment advice. Open the APRE and AMZN stock pages for the full models.
Not investment advice.